Bằng Chứng Hóa Học Thần Kinh Về Việc Điều Chỉnh Của Agmatine Đối Với Tính Độc Thần Kinh Của 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)

C. W. Tabor H. Tabor (1984) ArticleTitlePolyamines Annu. Rev. Biochem. 53 749–790 Occurrence Handle10.1146/annurev.bi.53.070184.003533 Occurrence Handle6206782 G. Li S. Regunathan C. J. Barrow J. Eshraghi R. Cooper D. J. Reis (1994) ArticleTitleAgmatine: An endogenous clonidine-displacing substance in the brain Science 263 966–969 Occurrence Handle7906055 C. A. Fairbanks K. L. Schreiber K. L. Brewer C.-G. Yu L. S. Stone K. F. Kitto H. O. Nguyen B. M. Grocholski D. W. Shoeman L. J. Kehl S. Regunathan D. J. Reis R. P. Yezierski G. L. Wilcox (2000) ArticleTitleAgmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury Proc. Natl. Acad. Sci. USA 97 10584–10589 Occurrence Handle10.1073/pnas.97.19.10584 Occurrence Handle10984543 G. M. Gilad V. H. Gilad J. M. Rabey (1996) ArticleTitleArginine and ornithine decarboxylation in rodent brain; coincidental changes during development and after ischemia Neurosci. Lett. 216 33–36 Occurrence Handle10.1016/0304-3940(96)12996-7 Occurrence Handle8892385 R. H. Loring (1990) ArticleTitleAgmatine acts as an antagonist of neuronal nicotinic receptors Br. J. Pharmacol. 99 207–211 Occurrence Handle2331571 G. Olmos N. DeGregorio-Rocasolano M. Paz Regalado T. Casull M. Assumpicio Boronat R. Trullas A. Villarroel J. Lerma J. A. Garcia-Sevilla (1999) ArticleTitleProtection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor Brit. J. Pharmacol. 127 1317–1326 Occurrence Handle10.1038/sj.bjp.0702679 D. Pinthong J. F. Hussain D. A. Kendall V. G. Wilson (1995) ArticleTitleComparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha(2)-adrenergic binding sites Brit. J. Pharmacol. 115 689–695 D. J. Reis S. Regunathan (1998) ArticleTitleAgmatine: A novel neurotransmitter? Adv. 42 645–649 X. C. Yang D. J. Reis (1999) ArticleTitleAgmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons J. Pharmacol. Exp. Therap. 288 544–549 R. M. Shepherd M. N. Hashmi C. Kane P. E. Squires M. J. Dunne (1996) ArticleTitleElevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: Implications for stimulus-response coupling of insulin release Brit. J. Pharmacol. 119 911–916 X.-C. Weng X.-D. Gai J.-Q. Zeng J. Li (2003) ArticleTitleAgmatine blocked voltage-gated calcium channel in cultured␣rat hippocampal neurons Acta Pharmacol. Sinica 24 746–750 M. Auguet I. Viossat J. G. Marin P. E. Chabrier (1995) ArticleTitleSelective inhibition of inducible nitric oxide synthase by agmatine Jap. J. Pharmacol. 69 285–287 Occurrence Handle8699639 E. Galea S. Regunathan V. Eliopoulus D. L. Feinstein D. J. Reis (1996) ArticleTitleInhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine Biochem. J. 316 247–249 Occurrence Handle8645212 G. M. Gilad Y. Wollman A. Iaina J. M. Rabey T. Chernihovsky V. H. Gilad (1996) ArticleTitleMetabolism of agmatine into urea but not into nitric oxide in rat brain NeuroReport 7 1730–1732 Occurrence Handle8905653 Y. Komori C. W. Guillermo J. M. Fukuto (1994) ArticleTitleInhibition of purified nitric oxide synthase from rat cerebellum and macrophage by L-arginine analogs Arch. Biochem. Biophys. 315 213–218 Occurrence Handle10.1006/abbi.1994.1492 Occurrence Handle7527206 T. Murayama S-.C. Tsai R. Adamik J. Moss M. Vaughan (1993) ArticleTitleEffects of temperature on ADP-ribosylation factor stimulation of cholera toxin activity Biochemistry 32 561–567 Occurrence Handle10.1021/bi00053a022 Occurrence Handle8422366 G. Weitzel B. Pfeiffer W. Stock (1980) ArticleTitleInsulin-like effects of agmatine derivatives in adipocytes, H.-S. Z Physiol. Chem. 361 51–60 G. M. Gilad V. H. Gilad (1992) ArticleTitleCommentary: Polyamines in neurotrauma: ubiquitous molecules in search of a function Biochem. Pharmacol. 44 401–407 Occurrence Handle10.1016/0006-2952(92)90428-L Occurrence Handle1510691 M. Marx G. Trittenwein C. Aufricht H. Hoeger B. Lubec (1995) ArticleTitleAgmatine and spermidine reduce collagen accumulation in kidneys of diabetic db/db mice Nephron 69 155–158 Occurrence Handle7723898 H. Vlassara R. Bocala L. Striker (1994) ArticleTitlePathogenic effects of advanced glycosylation: biochemical, biological, and clinical implications for diabetes and aging Lab. Invest. 70 138–151 Occurrence Handle8139257 G. M. Gilad V. H. Gilad (2000) ArticleTitleAccelerated functional recovery and neuroprotection by agmatine after spinal cord ischemia in rats Neurosci Lett. 296 97–100 Occurrence Handle10.1016/S0304-3940(00)01625-6 Occurrence Handle11108990 G. M. Gilad K. Salame J. M. Rabey V. H. Gilad (1995) ArticleTitleAgmatine treatment is neuroprotective in rodent brain injury models Life Sci. 58 PL41–PL46 Occurrence Handle10.1016/0024-3205(95)02274-0 Kim, J. H., Chun, H., Yenari, M., Giffard, R.G., Lee, W.T., Park, K.A., and Lee, J.E. 2002. Neuroprotective effect of agmatine on the cortical neurons in vitro ischemia-like condition and in vivo MCAO model of ischemia. Soc. Neurosci. Abst. Online Program No.: 391.12. Y. Z. Feng J. E. Piletz M. H. LeBlanc (2002) ArticleTitleAgmatine suppresses nitric oxide production and attenuates hypoxic-ischemic brain injury in neonatal rats Pediat. Res 52 606–611 Occurrence Handle10.1203/01.PDR.0000028057.79132.1F Occurrence Handle12357058 B. Pfeiffer W. Sarrazin G. Weitzel (1981) ArticleTitleInsulin-like effects of agmatine in vitro and in vivo H.-S. Z Physiol. Chem. 362 1331–1337 A. Sener P. Lebrun F. Blachier W. J. Malaisse (1988) ArticleTitleStimulus-secretion coupling of arginine-induced insulin release. Insulinotropic action of agmatine Biochem. Pharmacol. 38 327–330 Occurrence Handle10.1016/0006-2952(89)90044-0 W. Raasch U. Schafer J. Chun P. Dominiak (2001) ArticleTitleBiological significance of agmatine, an endogenous ligand at imidazoline binding sites J. Pharmacol. 133 755–780 M. K. Sun S. Regunathan D. J. Reis (1995) ArticleTitleCardiovascular response to agmatine, a clonidine-displacing substance, in anesthetized rat Clin. Exp. Hypertens. 17 115–128 Occurrence Handle7735262 F. AriciogluKartal I. T. Uzbay (1997) ArticleTitleInhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats Life Sci. 61 1775–1781 Occurrence Handle10.1016/S0024-3205(97)00801-1 Occurrence Handle9365224 Y. Kolesnikov S. Jain G. W. Pasternak (1996) ArticleTitleModulation of opioid analgesia by agmatine Eur. J. Pharmacol. 296 17–22 Occurrence Handle10.1016/0014-2999(95)00669-9 Occurrence Handle8720472 G. J. Molderings A. Heinen S. Menzel F. Lubbecke J. Homann M. Gothert (2003) ArticleTitleGastrointestinal uptake of agmatine: Distribution in tissues and organs and pathophysiologic relevance Ann. NY Acad. Sci. 1009 44–51 Occurrence Handle10.1196/annals.1304.005 Occurrence Handle15028569 J. E. Piletz P. J. May G. Wang H. Zhu (2003) ArticleTitleAgmatine crosses the blood–brain barrier Ann. NY Acad. Sci. 1009 44–51 Occurrence Handle10.1196/annals.1304.005 Occurrence Handle15028569 S. Regunathan C. Youngson W. Raasch H. Wang D. J. Reis (1996) ArticleTitleImidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation J. Pharmacol. Exp. Ther. 276 1272–1282 Occurrence Handle8786560 G. J. Molderings B. Kribben A. Heinen D. Schroder M. Bruss M. Gothert (2004) ArticleTitleIntestinal tumor and agmatine (decarboxylated arginine): Low content in colon carcinoma tissue specimens and inhibitory effect on tumor cell proliferation in vitro Cancer 101 858–868 Occurrence Handle10.1002/cncr.20407 Occurrence Handle15305420 I. J. Kopin (1987) ArticleTitleMPTP: An industrial chemical and contaminant of illicit narcotics stimulates a new era in research on Parkinson’s disease Environ. Health Perspect. 75 45–51 Occurrence Handle3319563 S. G. Speciale (2002) ArticleTitleMPTP. Insights into parkinsonian degeneration Neurotoxicol. Teratol. 24 607–620 Occurrence Handle10.1016/S0892-0362(02)00222-2 Occurrence Handle12200192 R. J. Smeyne V. Jackson-Lewis (2005) ArticleTitleThe MPTP model of Parkinson’s disease Mol. Brain Res. 134 57–66 Occurrence Handle10.1016/j.molbrainres.2004.09.017 Occurrence Handle15790530 G. M. Gilad D. J. Reis (1979) ArticleTitleCollateral sprouting in central mesolimbic dopamine neurons: Biochemical and immunocytochemical evidence of changes in the activity and distribution of tyrosine hydroxylase in terminal fields and in cell bodies of A10 neurons Brain Res. 160 17–36 Occurrence Handle10.1016/0006-8993(79)90597-3 Occurrence Handle31232 G. M. Gilad V. H. Gilad (1987) ArticleTitleAge-related reductions in brain cholinergic and dopaminergic indices in two rat strains differing in longevity Brain Res. 408 247–250 Occurrence Handle10.1016/0006-8993(87)90381-7 Occurrence Handle3594213 K. F. Tipton M. B. H. Youdim (1983) The assay of monoamine oxidase activity S. Parvez T. Nagatsu I. Nagatsu H. Parvez (Eds) Methods in Biogenic Amine Research Elsevier Amsterdam 441–467 A. M. O’carroll C. J. Fowler J. P. Phillip I. Tobia K. F. Tipton (1983) ArticleTitleThe deamination of dopamine by human brain monoamine oxidase. Specificity for the two forms in seven brain regions Naunyn Schmiedebergs Arch. Pharmacol. 322 198–207 Occurrence Handle10.1007/BF00500765 Occurrence Handle6408492 R. E. Heikkila L. Manzino F. S. Cabbat R.␣C Duvoisin (1984) ArticleTitleProtection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine by monoamine oxidase inhibitors Nature 311 467–469 Occurrence Handle10.1038/311467a0 Occurrence Handle6332989 J. A. Javitch R. J. D’Amato S. M. Strittmatter S. H. Snyder (1985) ArticleTitleParkinsonism inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenyl-pyridinium by dopamine neurons explain selective toxicity Proc. Natl. Acad. Sci. USA 82 2173–2177 Occurrence Handle3872460 M. W. Cleeter J. M. Cooper A. H. Schapira (1992) ArticleTitleIrreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement J. Neurochem. 58 786–789 Occurrence Handle1729421 D. C. Wu P. Teismann K. Tieu M. Vila V. Jackson-Lewis H. Ischiropoulos S. Przedborski (2003) ArticleTitleNADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine model of Parkinson’s disease Proc. Natl. Acad. Sci. USA 100 6145–6150 Occurrence Handle10.1073/pnas.0937239100 Occurrence Handle12721370 S. Przedborski M. Vila (2003) ArticleTitle1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine mouse model: A tool to explore the pathogenesis of Parkinson’s disease Ann. NY Acad. Sci. 991 189–198 Occurrence Handle12846987 D. Grundemann C. Hahne R. Berkels E. Schomig (2003) ArticleTitleAgmatine is efficiently transported by non-neuronal monoamine transporters extraneuronal monoamine transporter (EMT) and organic cation transporter 2 (OCT2) J. Pharmacol. Exp.Ther. 304 810–817 Occurrence Handle10.1124/jpet.102.044404 Occurrence Handle12538837